Northwest Biotherapeutics Announces Scientific Presentation on Propensity Score Matching at the British Neuro-Oncology Society Annual Meeting

Summary

Northwest Biotherapeutics announced a scientific presentation on propensity score matching by its Chief Technical Officer at the British Neuro-Oncology Society Annual Meeting. The presentation relates to the company's DCVax personalized immune therapies for solid tumor cancers.